The decisions by Pfizer and Merck to share their COVID-19 drug patents stands in stark contrast to the refusal of Pfizer and other vaccine-makers to release their vaccine recipes ...

Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...

Pfizer (NYSE:PFE) reported Phase 2b results for its GLP-1 anti-obesity candidate, PF-08653944, showing potential for a once ...

Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a market analyst who compared the drug to a rival injection from Pfizer. The comment comes as drugmakers race to meet ...

The company has not disclosed pricing or a launch timeline. The approval also comes as Novo Nordisk's Wegovy nears patent expiry later this month, potentially paving the way for lower-cost copycat ...

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

Pfizer says it's blocking use of its drugs for lethal injections, an announcement with limited immediate impact that nonetheless means all federally-approved drugmakers whose medications could be used ...

Novo Nordisk NVO and PfizerPFE are both pharmaceutical giants based in Denmark and the United States, respectively, with ...

WASHINGTON -- The pharmaceutical giant Pfizer tightened its policies Friday regarding the use of drugs in lethal injections, a move experts said would make it harder for states to carry out executions ...